<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Keratinopathic ichthyoses
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Keratinopathic ichthyoses
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Keratinopathic ichthyoses
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Keith Choate, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jennifer L Hand, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rosamaria Corona, MD, DSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Feb 22, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H917982233">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The keratinopathic ichthyoses (KPI) are a group of rare cornification disorders caused by mutations in one of the keratin genes, resulting in abnormalities of the keratin intermediate filaments, a component of the keratinocyte cell cytoskeleton. KPI encompass a spectrum of clinical phenotypes of varying severity. Disorders in the KPI group include epidermolytic ichthyosis, superficial epidermolytic ichthyosis, annular epidermolytic ichthyosis, ichthyosis Curth-Macklin, and ichthyosis with confetti [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         This topic will review the pathogenesis, clinical manifestations, diagnosis, and management of KPI. A general overview of the ichthyoses is presented separately. Recessive X-linked ichthyosis, Netherton syndrome, Sjögren-Larsson syndrome, and peeling skin syndrome are also discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15465.html" rel="external">
          "Overview and classification of the inherited ichthyoses"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15472.html" rel="external">
          "X-linked ichthyosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15474.html" rel="external">
          "Netherton syndrome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1699.html" rel="external">
          "Sjögren-Larsson syndrome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15512.html" rel="external">
          "Peeling skin syndromes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H839045007">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         In a French study, the prevalence of keratinopathic ichthyoses was estimated at approximately 1.1 per million, inclusive of epidermolytic ichthyosis, superficial epidermolytic ichthyosis, and annular epidermolytic ichthyosis, although others have estimated a frequency of nearly 3.3 per million worldwide [
         <a href="#rid2">
          2
         </a>
         ]. Annular epidermolytic ichthyosis, ichthyosis Curth-Macklin, and ichthyosis with confetti are exceedingly rare, with no reliable estimates of population incidence.
        </p>
        <p class="headingAnchor" id="H3056495443">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most cases of keratinopathic ichthyoses (KPI) result from either mutation arising de novo in the affected individual or via dominant inheritance from an affected parent, though there are rare reports of recessive mutations in
         <em>
          KRT10
         </em>
         causing epidermolytic ichthyosis. Linear epidermolytic ichthyosis appearing in patterns representing the dorsoventral migration patterns of keratinocyte precursors has also been described and results from somatic mutation in
         <em>
          KRT10
         </em>
         or
         <em>
          KRT1
         </em>
         [
         <a href="#rid3">
          3
         </a>
         ]. Generalized epidermolytic hyperkeratosis has been reported in the offspring of parents with linear epidermolytic epidermal nevus [
         <a href="#rid4">
          4-7
         </a>
         ].
         <strong>
         </strong>
         (See
         <a class="medical medical_review" href="/z/d/html/13728.html" rel="external">
          "Epidermal nevus and epidermal nevus syndrome", section on 'Pathogenesis'
         </a>
         .)
        </p>
        <p>
         Keratin intermediate filaments, a component of the keratinocyte cell cytoskeleton, are expressed in epithelia throughout the body, including in the skin, hair, and nails, and are central to structural integrity and skin barrier function [
         <a href="#rid8">
          8
         </a>
         ]. Keratin expression is both tissue and cell-type specific. In normal skin, keratin 5 and 14 are most abundant in the basal layer but are replaced by keratin 10 and 1 in the suprabasal layers of the epidermis during differentiation [
         <a href="#rid9">
          9
         </a>
         ].
         <em>
          KRT2
         </em>
         expression is further restricted to the upper spinous and granular layers of the skin [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         Keratins have amino and carboxy-terminal nonhelical domains and two highly conserved rod domains, which permit formation of heterodimers between coexpressed type 1 and type 2 keratins. Heterodimers oligomerize and further associate to form intermediate filaments [
         <a href="#rid11">
          11
         </a>
         ]. In K10, nonhelical domains have repeats of glycine and serine residues giving rise to a globular omega loop structure also present in other intermediate filaments and epidermal proteins, including corneodesmosin and loricrin [
         <a href="#rid12">
          12
         </a>
         ]. These globular domains array on the outside of the keratin fibril and are thought to stabilize filament organization and to direct interaction with other proteins containing similar globular domain structure. Keratin intermediate filaments provide mechanical strength to cells but also function in regulation of cell proliferation, growth, and differentiation [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2754387683">
         <span class="h1">
          CLINICAL PHENOTYPES
         </span>
        </p>
        <p class="headingAnchor" id="H2769190504">
         <span class="h2">
          Epidermolytic ichthyosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Epidermolytic ichthyosis, also called epidermolytic hyperkeratosis or bullous congenital ichthyosiform erythroderma (MIM #113800), is an autosomal dominant disorder of keratinization caused by mutations in the keratin 1 or 10 genes (
         <em>
          KRT1
         </em>
         and
         <em>
          KRT10
         </em>
         ). Epidermolytic ichthyosis is characterized by marked skin fragility with blistering and erythroderma at birth  (
         <a class="graphic graphic_picture graphicRef90570" href="/z/d/graphic/90570.html" rel="external">
          picture 1
         </a>
         ). Because of blistering and widespread erosions, epidermolytic ichthyosis can initially be mistaken for epidermolysis bullosa. (See
         <a class="medical medical_review" href="/z/d/html/15449.html" rel="external">
          "Epidermolysis bullosa: Epidemiology, pathogenesis, classification, and clinical features"
         </a>
         .)
        </p>
        <p>
         During childhood, blistering becomes less frequent, except at sites of trauma, and there is significant clinical heterogeneity in severity. Some individuals develop thick, corrugated scale most prominent at flexures  (
         <a class="graphic graphic_picture graphicRef90580 graphicRef90578" href="/z/d/graphic/90580.html" rel="external">
          picture 2A-B
         </a>
         ), while others develop palmoplantar keratoderma. The spectrum of epidermolytic ichthyosis presentations is correlated with the type of mutated keratin. Palmoplantar keratoderma is most commonly seen in patients with
         <em>
          KRT1
         </em>
         mutation, whereas a more generalized disease is more typically associated with
         <em>
          KRT10
         </em>
         mutation [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
         Skin infection is a frequent complication in infants and children, though symptoms tend to improve over time.
        </p>
        <p class="headingAnchor" id="H4080770422">
         <span class="h2">
          Minor variants
         </span>
         <span class="headingEndMark">
          —
         </span>
         Minor variants of keratinopathic ichthyoses include superficial epidermolytic ichthyosis, ichthyosis Curth-Macklin, ichthyosis with confetti, and annular epidermolytic ichthyosis (AEI).
        </p>
        <p class="headingAnchor" id="H4230093098">
         <span class="h3">
          Superficial epidermolytic ichthyosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Superficial epidermolytic ichthyosis (MIM #146800), previously called ichthyosis bullosa of Siemens, is caused by mutations in the
         <em>
          KRT2
         </em>
         gene [
         <a href="#rid10">
          10
         </a>
         ]. The clinical phenotypes of superficial epidermolytic ichthyosis tend to be less severe, due to the predominant expression of keratin 2 in the uppermost layers of the epidermis (upper stratum spinosum and stratum granulosum) [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
         Superficial epidermolytic ichthyosis presents at birth with generalized erythema and skin fragility similar to epidermolytic ichthyosis. In infancy and childhood, blistering can occur in response to trauma, particularly on the hands and feet, but tends to be less severe than that seen in epidermolytic ichthyosis. Hyperkeratosis is most prominent on the extremities, with corrugated scale evident at flexures. Erosions tend to be more superficial than in epidermolytic ichthyosis and can manifest as regions of peeling skin. Corrugated hyperkeratosis with dark brown skin develops mainly on the extremities.
        </p>
        <p class="headingAnchor" id="H2063292044">
         <span class="h3">
          Ichthyosis hystrix Curth-Macklin and ichthyosis Lambert type
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ichthyosis Curth-Macklin (MIM #146590) is a rare autosomal dominant disorder caused by mutation in
         <em>
          KRT10
         </em>
         . It presents with verrucous plaques involving the extensor aspects of arms and legs and palmoplantar keratoderma. A related disorder, ichthyosis hystrix Lambert type (MIM #146600), caused by mutations in
         <em>
          KRT10
         </em>
         ,
         <em>
         </em>
         is characterized by more generalized verrucous plaques involving the entire body, with accentuation at extensor surfaces and less prominent palmoplantar keratoderma  (
         <a class="graphic graphic_picture graphicRef111429" href="/z/d/graphic/111429.html" rel="external">
          picture 3
         </a>
         ) [
         <a href="#rid16">
          16-18
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4082302674">
         <span class="h3">
          Ichthyosis with confetti
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ichthyosis with confetti (IWC; MIM #609165), also called congenital reticular ichthyosiform erythroderma or ichthyosis variegata, is a rare autosomal dominant disorder caused by frameshift mutations in
         <em>
          KRT1
         </em>
         or
         <em>
          KRT10
         </em>
         genes [
         <a href="#rid19">
          19,20
         </a>
         ].
        </p>
        <p>
         IWC presents at birth with generalized ichthyosiform erythroderma or a collodion baby and palmoplantar keratoderma. During childhood or adolescence, patients develop hundreds of confetti-like white spots of normal skin on a background of scaling erythroderma. These spots, which increase in number and size over time, result from revertant mosaicism, due to local spontaneous replacement of mutated
         <em>
          KRT1
         </em>
         or
         <em>
          KRT10
         </em>
         genes by wild-type alleles via mitotic recombination [
         <a href="#rid19">
          19,21-23
         </a>
         ].
        </p>
        <p>
         Additional clinical features of IWC include ear deformities, severe palmoplantar keratoderma, hypertrichosis, eclabium (outward lip eversion), and ectropion.
        </p>
        <p class="headingAnchor" id="H2706357129">
         <span class="h3">
          Annular epidermolytic ichthyosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         AEI is characterized by blistering and scaling at birth and in the perinatal period with subsequent development of annular or polycyclic hyperkeratotic lesions that can appear and resolve. Specific mutations in
         <em>
          KRT1
         </em>
         and
         <em>
          KRT10
         </em>
         have been identified that cause AEI [
         <a href="#rid24">
          24-26
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3242199811">
         <span class="h1">
          PATHOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         On histopathologic examination, epidermolytic ichthyosis shows a thickened, acanthotic epidermis with hyperkeratosis, hypergranulosis, vacuolar degeneration of the stratum spinosum (epidermolysis), and coarse keratohyalin granules in the granular layer. Superficial epidermolytic ichthyosis shows similar features with epidermolysis in the granular layer [
         <a href="#rid27">
          27
         </a>
         ]. Electron microscopy shows clumping of intermediate filament fibrils, which leads to cellular fragility via disruption of intermediate filaments, apoptosis, and cell proliferation [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
         Ichthyosis hystrix Curth-Macklin and Lambert type both feature acanthosis, hyperkeratosis, an absent granular layer, and perinuclear vacuolization due to tonofilament collapse without evidence of epidermolysis [
         <a href="#rid18">
          18
         </a>
         ]. Milder epidermolytic ichthyosis phenotypes also appear to result from filament network collapse rather than filament clumping, leading to lower rates of apoptosis and markedly less severe cell fragility [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
         Ichthyosis with confetti due to
         <em>
          KRT10
         </em>
         mutation features acanthosis, perinuclear vacuolization, hyperkeratosis, and parakeratosis [
         <a href="#rid10">
          10
         </a>
         ], while ichthyosis with confetti due to
         <em>
          KRT1
         </em>
         mutation features acanthosis, hyperkeratosis, and hypergranulosis [
         <a href="#rid19">
          19
         </a>
         ]. Ichthyosis with confetti due to mutations affecting the nonhelical end domains of K1 and K10 shows on electron microscopy poor investment of desmosomes with keratin intermediate filaments and filament network collapse, with intranuclear accumulation of both proteins [
         <a href="#rid19">
          19,21
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3390897942">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Early consultation with a dermatologist can aid in the diagnosis of keratinopathic ichthyosis in the neonatal period. Newborns with epidermolytic ichthyosis presenting with widespread skin erosions are sometimes misdiagnosed as having epidermolysis bullosa, particularly in cases with a negative family history. Although both disorders can present with areas of denuded skin, a skin biopsy suggests the correct diagnosis. In contrast with epidermolysis bullosa, which shows a subepidermal or intraepidermal cleft, epidermolytic ichthyosis is characterized by hypergranulosis and lysis of the epidermis above the basal layer. Genetic testing for
         <em>
          KRT1
         </em>
         ,
         <em>
          KRT2
         </em>
         ,
         <em>
         </em>
         and
         <em>
          KRT10
         </em>
         mutations can confirm the diagnosis.
        </p>
        <p>
         In adults, the diagnosis of superficial epidermolytic ichthyosis, epidermolytic ichthyosis, or ichthyosis with confetti is suspected based upon the clinical findings and disease history. Examination of a skin biopsy and genetic testing can be performed to confirm the diagnosis. It is important to note that a large fraction of cases are due to de novo mutations present in the affected individual but not in other family members. Such individuals are at risk, however, of transmitting the mutated allele to future generations.
        </p>
        <p class="headingAnchor" id="H3350427157">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         In neonates and young infants, congenital or acquired disorders that should be considered in the differential diagnosis of keratinopathic ichthyosis include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Epidermolysis bullosa  (
         <a class="graphic graphic_picture graphicRef86267" href="/z/d/graphic/86267.html" rel="external">
          picture 4
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/15452.html" rel="external">
          "Diagnosis of epidermolysis bullosa"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Staphylococcal scalded skin syndrome  (
         <a class="graphic graphic_picture graphicRef72261" href="/z/d/graphic/72261.html" rel="external">
          picture 5
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/5790.html" rel="external">
          "Vesicular, pustular, and bullous lesions in the newborn and infant", section on 'Staphylococcal scalded skin syndrome'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Aplasia cutis congenita  (
         <a class="graphic graphic_picture graphicRef77708" href="/z/d/graphic/77708.html" rel="external">
          picture 6
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/5790.html" rel="external">
          "Vesicular, pustular, and bullous lesions in the newborn and infant", section on 'Aplasia cutis congenita'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital herpes simplex virus infection  (
         <a class="graphic graphic_picture graphicRef75059" href="/z/d/graphic/75059.html" rel="external">
          picture 7
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sucking blisters  (
         <a class="graphic graphic_picture graphicRef67302" href="/z/d/graphic/67302.html" rel="external">
          picture 8
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         In adults, conditions that may mimic keratinopathic ichthyosis include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Erythrokeratodermia variabilis et progressiva (EKVP) – The erythrokeratodermias are a heterogeneous group of inherited keratinization disorders characterized by fixed or migratory erythematous plaques and fixed hyperkeratotic plaques, often in association with palmoplantar keratoderma [
         <a href="#rid29">
          29,30
         </a>
         ]. Lesions appear during infancy, progress during childhood, and then become stable. EKVP is caused by mutations in the connexin genes
         <em>
          GJB3
         </em>
         ,
         <em>
          GJB4
         </em>
         , and
         <em>
          GJA1
         </em>
         [
         <a href="#rid30">
          30-32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Palmoplantar keratodermas (Vohwinkel syndrome, Papillon-Lefèvre syndrome, Unna-Thost keratoderma). (See
         <a class="medical medical_review" href="/z/d/html/3004.html" rel="external">
          "The genodermatoses: An overview", section on 'Palmoplantar keratodermas'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Erythrokeratodermia-cardiomyopathy syndrome – Erythrokeratodermia-cardiomyopathy syndrome is a condition associated with mutations in the desmoplakin gene (
         <em>
          DSP
         </em>
         ) and characterized by erythrokeratodermia, progressive cardiomyopathy, and dental enamel and nail abnormalities [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4194248256">
         <span class="h1">
          MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The management of patients with keratinopathic ichthyoses involves a close collaboration between dermatologists and pediatricians or primary care providers and specialists as needed. Given the rarity of keratinopathic ichthyoses, the approach to treatment is mainly based upon clinical experience and very limited evidence from small case series and single case reports. (See
         <a class="medical medical_review" href="/z/d/html/128456.html" rel="external">
          "Inherited ichthyosis: Overview of management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H363492380">
         <span class="h2">
          General measures
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the newborn period, if blistering is prominent, treatment is focused on wound healing and prevention of infection and dehydration [
         <a href="#rid34">
          34
         </a>
         ]. Liberal application of petrolatum-based emollients with nonstick dressings favors the re-epithelialization. Beyond the neonatal period, blistering tends to be restricted to pressure and friction-bearing areas, and efforts to reduce friction can ameliorate the disease. When blisters are present, monitoring for signs of infection such as fever or tenderness or redness near sites of blistering is advised.
        </p>
        <p>
         Over time, most patients will develop hyperkeratosis of the skin and/or palms and soles. Hyperkeratosis can lead to accumulation of scale on the body with formation of thick, corrugated hyperkeratosis and to painful fissuring on the palms and soles. Odor due to bacterial colonization of hyperkeratotic areas is common and is a source of considerable distress for patients. Long bathtub soaks can aid in removing scale, and intermittent diluted bleach baths can decrease colonization with pathogenic microbes and odor associated with hyperkeratosis. A diluted bleach bath is prepared by adding 0.5 cup or 120 mL of 6% bleach in a full bathtub (40 gallons or 150 L) of lukewarm water.
        </p>
        <p>
         Petrolatum and other bland emollients, humectants, and keratolytics can soften and remove scale and make palms and soles more pliable. In the setting of thick hyperkeratosis on the palms and soles, affected individuals and their caregivers may choose to pare or sand callouses.
        </p>
        <p class="headingAnchor" id="H2678069392">
         <span class="h2">
          Topical and systemic retinoids
         </span>
         <span class="headingEndMark">
          —
         </span>
         Topical and systemic retinoids can be effective in reducing hyperkeratosis and palmoplantar keratoderma. Topical retinoids such as
         <a class="drug drug_general" data-topicid="9665" href="/z/d/drug information/9665.html" rel="external">
          tazarotene
         </a>
         or tretinoin can be applied to focal areas once daily in small amounts. The primary side effect of such therapy is local irritation, which may require a reduction in frequency (to once or twice weekly, for example) or amount of application.
        </p>
        <p>
         When hyperkeratosis is severe, time spent grooming is excessive, or when more widespread improvement in skin appearance is sought, systemic retinoids including
         <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">
          isotretinoin
         </a>
         and
         <a class="drug drug_general" data-topicid="9250" href="/z/d/drug information/9250.html" rel="external">
          acitretin
         </a>
         may be a therapeutic option. Both are oral medications administered at doses ranging from 0.2 to 1.5 mg/kg/day. Given the tendency of these medications to worsen skin fragility, it is advisable to start with a low dose and titrate gradually to efficacy, with a goal of using the lowest dose possible to achieve efficacy.
        </p>
        <p>
         Dryness of the skin, lips, and eyes is a common adverse effect of systemic retinoids. Other adverse effects include hypertriglyceridemia, mood changes, and ectopic calcification of tendons and ligaments. While adverse effects can be concerning to patients and their families/caregivers, systemic retinoids can lead to significant improvement of skin appearance, quality of life, and ability to conduct activities of daily living.
        </p>
        <p>
         Monitoring for hypertriglyceridemia and hepatotoxicity are required with retinoid therapy. Systemic retinoids are teratogenic and must not be used during pregnancy. Pregnancy is contraindicated for
         <strong>
          three years
         </strong>
         after discontinuing
         <a class="drug drug_general" data-topicid="9250" href="/z/d/drug information/9250.html" rel="external">
          acitretin
         </a>
         . In women of child-bearing potential,
         <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">
          isotretinoin
         </a>
         is preferred to acitretin because of its shorter half-life; pregnancy is contraindicated for one month after discontinuing isotretinoin.
        </p>
        <p class="headingAnchor" id="H3959050815">
         <span class="h1">
          PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Given the rarity of keratinopathic ichthyoses, long-term studies of disease natural history have not been performed. Improvements in neonatal intensive care have reduced complications in the perinatal period, and early demise is very rare. Affected individuals have normal intelligence, and there is no evidence of reduced lifespan. The skin may require lifelong care. Initiation of social services to help the patient seek resources and providing contact with a patient support group, such as the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.firstskinfoundation.org%2F&amp;token=oN6rXOmeBLkIpfIsq5mH5Z0Le%2Fvc5VRvejbPvZqw%2FIYldSRDD4QEGzmgJ%2BviBi8p&amp;TOPIC_ID=97333" target="_blank">
          Foundation for Ichthyosis and Related Skin Types (FIRST)
         </a>
         , may be beneficial.
        </p>
        <p>
         Since most keratinopathic ichthyoses are inherited in an autosomal dominant manner, there is significant risk of an affected individual having affected offspring. Genetic counseling can be useful to discuss genetic diagnosis and family planning options, including preimplantation genetic testing. (See
         <a class="medical medical_review" href="/z/d/html/6783.html" rel="external">
          "Preimplantation genetic testing"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1390066946">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         – The keratinopathic ichthyoses (KPI) are a group of rare cornification disorders caused by autosomal dominant mutations in the keratin genes
         <em>
          KRT1
         </em>
         ,
         <em>
          KRT10
         </em>
         , and
         <em>
          KRT2
         </em>
         . (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical phenotypes
         </strong>
         – KPI encompass a spectrum of clinical phenotypes of varying severity, including epidermolytic ichthyosis, superficial epidermolytic ichthyosis, ichthyosis hystrix Curth-Macklin  (
         <a class="graphic graphic_picture graphicRef111429" href="/z/d/graphic/111429.html" rel="external">
          picture 3
         </a>
         ), ichthyosis with confetti, and annular epidermolytic ichthyosis. Epidermolytic ichthyosis presents at birth with marked skin fragility with blistering and erythroderma. Older children and adults may develop thick, corrugated scale most prominent at flexures  (
         <a class="graphic graphic_picture graphicRef90580 graphicRef90578" href="/z/d/graphic/90580.html" rel="external">
          picture 2A-B
         </a>
         ). (See
         <a class="local">
          'Clinical phenotypes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of KPI is based upon the clinical appearance and the examination of a skin biopsy. Histology typically shows epidermolytic hyperkeratosis (a thickened epidermis with hyperkeratosis, hypergranulosis, vacuolar degeneration of the stratum spinosum, and coarse keratohyalin granules in the granular layer). (See
         <a class="local">
          'Diagnosis'
         </a>
         above and
         <a class="local">
          'Pathology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – In the newborn, treatment is focused on wound healing and prevention of infection and dehydration. Liberal application of petrolatum-based emollients with nonstick dressings favors the re-epithelialization. In older children and adults, treatment is directed at reducing the scale and softening the skin. Topical retinoids (eg,
         <a class="drug drug_general" data-topicid="9665" href="/z/d/drug information/9665.html" rel="external">
          tazarotene
         </a>
         , tretinoin) can be applied daily to focal areas. In patients with severe and extensive hyperkeratosis, systemic retinoids (eg,
         <a class="drug drug_general" data-topicid="9250" href="/z/d/drug information/9250.html" rel="external">
          acitretin
         </a>
         ,
         <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">
          isotretinoin
         </a>
         ) are a therapeutic option. (See
         <a class="local">
          'Management'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Oji V, Tadini G, Akiyama M, et al. Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol 2010; 63:607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dreyfus I, Chouquet C, Ezzedine K, et al. Prevalence of inherited ichthyosis in France: a study using capture-recapture method. Orphanet J Rare Dis 2014; 9:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsubota A, Akiyama M, Sakai K, et al. Keratin 1 gene mutation detected in epidermal nevus with epidermolytic hyperkeratosis. J Invest Dermatol 2007; 127:1371.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reddy BS, Thadeus J, Kumar SK, et al. Generalized epidermolytic hyperkeratosis in a child born to a parent with systematized epidermolytic linear epidermal nevus. Int J Dermatol 1997; 36:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akhyani M, Kiavash K, Kamyab K. Bullous ichthyosiform erythroderma in a child born to a parent with systematized linear epidermolytic hyperkeratosis. Int J Dermatol 2009; 48:215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chassaing N, Kanitakis J, Sportich S, et al. Generalized epidermolytic hyperkeratosis in two unrelated children from parents with localized linear form, and prenatal diagnosis. J Invest Dermatol 2006; 126:2715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kono M, Suga Y, Akashi T, et al. A Child with Epidermolytic Ichthyosis from a Parent with Epidermolytic Nevus: Risk Evaluation of Transmission from Mosaic to Germline. J Invest Dermatol 2017; 137:2024.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haines RL, Lane EB. Keratins and disease at a glance. J Cell Sci 2012; 125:3923.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhou XM, Idler WW, Steven AC, et al. The complete sequence of the human intermediate filament chain keratin 10. Subdomainal divisions and model for folding of end domain sequences. J Biol Chem 1988; 263:15584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cervantes T, Pham C, Browning JC. Superficial epidermolytic ichthyosis: a report of two families. Pediatr Dermatol 2013; 30:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steinert PM. Analysis of the mechanism of assembly of mouse keratin 1/keratin 10 intermediate filaments in vitro suggests that intermediate filaments are built from multiple oligomeric units rather than a unique tetrameric building block. J Struct Biol 1991; 107:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steinert PM, Mack JW, Korge BP, et al. Glycine loops in proteins: their occurrence in certain intermediate filament chains, loricrins and single-stranded RNA binding proteins. Int J Biol Macromol 1991; 13:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santos M, Paramio JM, Bravo A, et al. The expression of keratin k10 in the basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis. J Biol Chem 2002; 277:19122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DiGiovanna JJ, Bale SJ. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 1994; 130:1026.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol 2008; 129:705.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kubo Y, Urano Y, Matsuda R, et al. Ichthyosis hystrix, Curth-Macklin type: a new sporadic case with a novel mutation of keratin 1. Arch Dermatol 2011; 147:999.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nayak S, Acharjya B, Mohanty P. Ichthyosis hystrix. Indian Dermatol Online J 2013; 4:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang WH, Zhang L, Li LF, Sun TT. Ichthyosis hystrix Lambert type and Curth-Macklin type are a single entity with affected (KRT1 mutation) or unaffected (KRT10 mutation) palms and soles? Eur J Dermatol 2016; 26:493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choate KA, Lu Y, Zhou J, et al. Frequent somatic reversion of KRT1 mutations in ichthyosis with confetti. J Clin Invest 2015; 125:1703.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choate KA, Lu Y, Zhou J, et al. Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10. Science 2010; 330:94.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choate KA, Lu Y, Zhou J, et al. Ichthyosis with confetti shows widespread somatic reversion via mitotic recombination at two distinct loci. J Invest Dermatol 2011; 131:S64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choate KA, Milstone LM. Phenotypic expansion in ichthyosis with confetti. JAMA Dermatol 2015; 151:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lim YH, Qiu J, Saraceni C, et al. Genetic Reversion via Mitotic Recombination in Ichthyosis with Confetti due to a KRT10 Polyalanine Frameshift Mutation. J Invest Dermatol 2016; 136:1725.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sahn EE, Weimer CE Jr, Garen PD. Annular epidermolytic ichthyosis: a unique phenotype. J Am Acad Dermatol 1992; 27:348.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joh GY, Traupe H, Metze D, et al. A novel dinucleotide mutation in keratin 10 in the annular epidermolytic ichthyosis variant of bullous congenital ichthyosiform erythroderma. J Invest Dermatol 1997; 108:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sybert VP, Francis JS, Corden LD, et al. Cyclic ichthyosis with epidermolytic hyperkeratosis: A phenotype conferred by mutations in the 2B domain of keratin K1. Am J Hum Genet 1999; 64:732.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ross R, DiGiovanna JJ, Capaldi L, et al. Histopathologic characterization of epidermolytic hyperkeratosis: a systematic review of histology from the National Registry for Ichthyosis and Related Skin Disorders. J Am Acad Dermatol 2008; 59:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mirza H, Kumar A, Craiglow BG, et al. Mutations Affecting Keratin 10 Surface-Exposed Residues Highlight the Structural Basis of Phenotypic Variation in Epidermolytic Ichthyosis. J Invest Dermatol 2015; 135:3041.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirano SA, Harvey VM. From progressive symmetric erythrokeratoderma to erythrokeratoderma variabilis progressiva. J Am Acad Dermatol 2011; 64:e81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyden LM, Craiglow BG, Zhou J, et al. Dominant De Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis et Progressiva, without Features of Oculodentodigital Dysplasia. J Invest Dermatol 2015; 135:1540.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richard G, Smith LE, Bailey RA, et al. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet 1998; 20:366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Macari F, Landau M, Cousin P, et al. Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis. Am J Hum Genet 2000; 67:1296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyden LM, Kam CY, Hernández-Martín A, et al. Dominant de novo DSP mutations cause erythrokeratodermia-cardiomyopathy syndrome. Hum Mol Genet 2016; 25:348.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Avril M, Riley C. Management of Epidermolytic Ichthyosis in the Newborn. Neonatal Netw 2016; 35:19.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 97333 Version 5.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20643494" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24393603" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Prevalence of inherited ichthyosis in France: a study using capture-recapture method.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17255957" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Keratin 1 gene mutation detected in epidermal nevus with epidermolytic hyperkeratosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9159002" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Generalized epidermolytic hyperkeratosis in a child born to a parent with systematized epidermolytic linear epidermal nevus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19200214" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Bullous ichthyosiform erythroderma in a child born to a parent with systematized linear epidermolytic hyperkeratosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16990804" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Generalized epidermolytic hyperkeratosis in two unrelated children from parents with localized linear form, and prenatal diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28532675" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : A Child with Epidermolytic Ichthyosis from a Parent with Epidermolytic Nevus: Risk Evaluation of Transmission from Mosaic to Germline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23104737" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Keratins and disease at a glance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2459124" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The complete sequence of the human intermediate filament chain keratin 10. Subdomainal divisions and model for folding of end domain sequences.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22612346" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Superficial epidermolytic ichthyosis: a report of two families.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1725490" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Analysis of the mechanism of assembly of mouse keratin 1/keratin 10 intermediate filaments in vitro suggests that intermediate filaments are built from multiple oligomeric units rather than a unique tetrameric building block.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1716976" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Glycine loops in proteins: their occurrence in certain intermediate filament chains, loricrins and single-stranded RNA binding proteins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11889133" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The expression of keratin k10 in the basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8053700" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Clinical heterogeneity in epidermolytic hyperkeratosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18461349" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The human keratins: biology and pathology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21844476" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Ichthyosis hystrix, Curth-Macklin type: a new sporadic case with a novel mutation of keratin 1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23440302" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Ichthyosis hystrix.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27212473" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Ichthyosis hystrix Lambert type and Curth-Macklin type are a single entity with affected (KRT1 mutation) or unaffected (KRT10 mutation) palms and soles?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25774499" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Frequent somatic reversion of KRT1 mutations in ichthyosis with confetti.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20798280" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Ichthyosis with confetti shows widespread somatic reversion via mitotic recombination at two distinct loci
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25210951" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Phenotypic expansion in ichthyosis with confetti.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27208707" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Genetic Reversion via Mitotic Recombination in Ichthyosis with Confetti due to a KRT10 Polyalanine Frameshift Mutation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1517502" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Annular epidermolytic ichthyosis: a unique phenotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9036939" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : A novel dinucleotide mutation in keratin 10 in the annular epidermolytic ichthyosis variant of bullous congenital ichthyosiform erythroderma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10053007" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Cyclic ichthyosis with epidermolytic hyperkeratosis: A phenotype conferred by mutations in the 2B domain of keratin K1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18571597" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Histopathologic characterization of epidermolytic hyperkeratosis: a systematic review of histology from the National Registry for Ichthyosis and Related Skin Disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26176760" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Mutations Affecting Keratin 10 Surface-Exposed Residues Highlight the Structural Basis of Phenotypic Variation in Epidermolytic Ichthyosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21496691" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : From progressive symmetric erythrokeratoderma to erythrokeratoderma variabilis progressiva.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25398053" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Dominant De Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis et Progressiva, without Features of Oculodentodigital Dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9843209" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11017804" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26604139" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Dominant de novo DSP mutations cause erythrokeratodermia-cardiomyopathy syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26842536" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Management of Epidermolytic Ichthyosis in the Newborn.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
